Evidence map›Paper›PMID 33413359›Full record

ArticleBMC complementary medicine and therapies2021

Norwogonin attenuates hypoxia-induced oxidative stress and apoptosis in PC12 cells.

Linlin Jing, Rongmin Gao, Jie Zhang, Dongmei Zhang, Jin Shao, Zhengping Jia, Huiping Ma

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Nutrients · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Recent advances inHeliyon · 2024
    Review
  7. Synthesis, antioxidant and antiZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  8. Exercise performance reduction and preventive measures in highland sports.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  9. Article
  10. Exploring the Mechanism ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  11. Effective Parts ofDose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Linlin JingDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China.
Rongmin GaoDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China.
Jie ZhangDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China.
Dongmei ZhangDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China.
Jin ShaoDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China.
Zhengping JiaDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China.
Huiping MaDepartment of Pharmacy, the 940th Hospital of Joint Logistics Support force of PLA, Lanzhou, 730050, Gansu, China. huipingmacyk@163.com.ORCID http://orcid.org/0000-0003-4560-2155
82th Hospital of Pla · CN

Funding

National Natural Science Foundation of China 81202458National Natural Science Foundation of China 81571847National Natural Science Foundation of China 81872796Natural Science Foundation of Gansu Province 1308RJYA061Natural Science Foundation of Gansu Province 145RJZA089Natural Science Foundation of Gansu Province 18JR3RA408Postdoctoral Research Foundation of China 2015ZXKF09The Logistics Research Program of PLA CWH17J010
6 · The paper itself

Abstract

backgroundNorwogonin is a natural flavone with three phenolic hydroxyl groups in skeletal structure and has excellent antioxidant activity. However, the neuroprotective effect of norwogonin remains unclear. Here, we investigated the protective capacity of norwogonin against oxidative damage elicited by hypoxia in PC12 cells.

methodsThe cell viability and apoptosis were examined by MTT assay and Annexin V-FITC/PI staining, respectively. Reactive oxygen species (ROS) content was measured using DCFH-DA assay. Lactate dehydrogenase (LDH), malondialdehyde (MDA) and antioxidant enzyme levels were determined using commercial kits. The expression of related genes and proteins was measured by real-time quantitative PCR and Western blotting, respectively.

resultsWe found that norwogonin alleviated hypoxia-induced injury in PC12 cells by increasing the cell viability, reducing LDH release, and ameliorating the changes of cell morphology. Norwogonin also acted as an antioxidant by scavenging ROS, reducing MDA production, maintaining the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx), and decreasing the expression levels of HIF-1α and VEGF. In addition, norwogonin prevented cell apoptosis via inhibiting the expression levels of caspase-3, cytochrome c and Bax, while increasing the expression levels of Bcl-2 and the ratio of Bcl-2/Bax.

conclusionsNorwogonin attenuates hypoxia-induced injury in PC12 cells by quenching ROS, maintaining the activities of antioxidant enzymes, and inhibiting mitochondrial apoptosis pathway.

Indexed as

AnimalsAntioxidantsApoptosisCell SurvivalDrugs, Chinese HerbalFlavonesHypoxia-Inducible Factor 1, alpha SubunitMitochondriaNeuroprotective AgentsOxidative StressOxygenPC12 CellsRatsReactive Oxygen SpeciesScutellaria baicalensisVascular Endothelial Growth Factor AAntioxidantsDrugs, Chinese HerbalFlavonesHif1a protein, ratHypoxia-Inducible Factor 1, alpha SubunitNeuroprotective AgentsnorwogoninOxygenReactive Oxygen SpeciesVascular Endothelial Growth Factor Avascular endothelial growth factor A, ratAntioxidant activityApoptosisHypoxiaNorwogoninOxidative stress

Identifiers

PMID33413359
PMCPMC7791982
OpenAlexW3119438962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.